Skip to main content

ELISA

Our gastroenterology ELISA portfolio provides specialized in vitro diagnostic assays for the investigation of celiac disease, inflammatory bowel disease (IBD), autoimmune gastritis, pancreatic disorders, and Helicobacter pylori-associated conditions.

The portfolio includes serological ELISA assays for detecting disease-associated IgA and IgG antibodies against tissue transglutaminase, deamidated gliadin peptides, Saccharomyces cerevisiae antigens (ASCA), and glycoprotein 2 (GP2). Additional assays detect antibodies against gastric parietal cells and intrinsic factor, supporting the diagnostic work-up of autoimmune gastritis. A stool-based ELISA for H. pylori antigen complements the portfolio.

Designed for standard microplate workflows, the assays support efficient single-marker analysis in routine laboratories. Ready-to-use or optimized reagents, standardized protocols, and qualitative or quantitative result interpretation—depending on the assay—enable reliable integration into gastroenterology diagnostics.

Contact us